Effects of different frequency of Baduanjin on glucose metabolism and sleep quality in schizophrenia patients with prediabetes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400085137

Enrollment

Unknown

Registered

2024-05-31

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia prediabetes

Interventions

Conventional treatment group:Routine lifestyle intervention.

Baduanjin treatment group once a day:Routine lifestyle intervention plus practice eight highlights, once a day.

Baduanjin treatment group twice a day:Routine lifestyle intervention plus practice eight highlights, twice a day.

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with schizophrenia according to ICD-10 criteria by psychiatrists with associate chief physician or above were initially enrolled and met the following conditions: (1) In accordance with the diagnostic criteria for prediabetes in the Chinese Diabetes Prevention and Treatment Guidelines, that is, FBG: 6.1mmol/L=FBG < 7.0mmol/L, and oral glucose tolerance test (OGTT), 2hBG < 7.8mmol/L; IGT: FBG < 7.0mmol/L, 7.8mmol/L=OGTT,2hBG < 11.1mmol/L, in line with the above two standards. (2) Age =18 years old; (3) The patient was in a stable stage of schizophrenia; (4) Have certain cognitive ability and physical exercise ability; (5) Be able to cooperate with the completion of this research; (6) Obtain the informed consent of the patient himself or his guardian, and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Diabetes mellitus has been diagnosed; (2) Patients with severe hypertension (low pressure higher than 110mmHg, high pressure higher than 180mmHg); (3) The use of hormone drugs; (4) Patients with fundus, nervous system, kidney, heart and plantar lesions caused by other diseases; (5) Patients who are unable to complete the intervention as required for various reasons.

Design outcomes

Primary

Measure	Time frame
Blood glucose related index;sleep quality;	—

Secondary

Measure	Time frame
mental state;living quality;Body-related index;	—

Countries

China

Contacts

Public ContactChunxia Ban

Mental Health Center of Jiading District in Shangha

15576659@qq.com+86 138 1671 3076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026